Naif M Alhawiti, Mamdouh M Shubair, Seema Mohammed Nasser, Amani Alharthy, Badr F Al-Khateeb, Fatmah Othman, Awad Alshahrani, Lubna Alnaim, Abdulmajeed Abdullah Abukhamis, Noof Alwatban, Ashraf El-Metwally
{"title":"Predictors of Blood Pressure, Cholesterol, and Cardiovascular Screening Among Saudis at Primary Healthcare Settings in Riyadh, Saudi Arabia.","authors":"Naif M Alhawiti, Mamdouh M Shubair, Seema Mohammed Nasser, Amani Alharthy, Badr F Al-Khateeb, Fatmah Othman, Awad Alshahrani, Lubna Alnaim, Abdulmajeed Abdullah Abukhamis, Noof Alwatban, Ashraf El-Metwally","doi":"10.2147/PPA.S516304","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>This study was conducted to estimate proportion of individuals undergoing screening for cardiovascular disease (CVD) and its risk factors and to identify predictors of CVD, blood pressure, and blood cholesterol screening.</p><p><strong>Patients and methods: </strong>This cross-sectional study was conducted in 48 primary healthcare centers in Saudi Arabia and 14,239 participants were enrolled. The analysis was performed in SPSS version 26 and adjusted odds ratios (AOR) and 95% Cis were reported.</p><p><strong>Results: </strong>Blood pressure screening was reported by 35.3%, cholesterol screening by 9.3%, and cardiovascular screening by 3.7%. Significant positive predictors for blood pressure screening included older age (50-75 years: AOR 1.34, 95% CI: 1.20-1.50; ≥75 years: AOR 2.12, 95% CI: 1.84-2.43), being married (AOR: 1.15; 95% CI: 1.04-1.27), non-smoking (AOR: 1.97; 95% CI: 1.79-2.17), physical activity (AOR: 1.16; 95% CI: 1.05-1.28), and diabetes (AOR: 2.14; 95% CI: 1.88-2.44). For cholesterol screening, significant positive predictors were older age (≥75 years: AOR 1.89, 95% CI: 1.56-2.29), unemployment (AOR: 1.26; 95% CI: 1.10-1.45), insurance coverage (AOR: 1.52; 95% CI: 1.33-1.74), smoking (AOR: 1.32; 95% CI: 1.14-1.53), diabetes history (AOR: 1.33; 95% CI: 1.09-1.61), and hypertension (AOR: 1.66; 95% CI: 1.36-2.02). For cardiovascular screening, significant positive predictors included older age (≥75 years: AOR 1.81, 95% CI: 1.35-2.43), unemployment (AOR: 1.53; 95% CI: 1.24-1.88), insurance coverage (AOR: 1.56; 95% CI: 1.27-1.92), smoking (AOR: 1.89; 95% CI: 1.52-2.34), diabetes (AOR: 1.85; 95% CI: 1.41-2.43), and high cholesterol (AOR: 1.76; 95% CI: 1.31-2.36).</p><p><strong>Conclusion: </strong>A very low proportion of Saudi residents have undergone blood pressure, cholesterol, and CVD screening. Common predictors of screening included older age, insurance coverage, diabetes, hypertension, physical activity, and high cholesterol levels. Low prevalence of screening is alarming, and Saudi Government needs to implement strategies that can help increase proportion of Saudi residents who receive blood pressure, cholesterol, and CVD screening.</p>","PeriodicalId":19972,"journal":{"name":"Patient preference and adherence","volume":"19 ","pages":"1433-1447"},"PeriodicalIF":2.0000,"publicationDate":"2025-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12085128/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Patient preference and adherence","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/PPA.S516304","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose: This study was conducted to estimate proportion of individuals undergoing screening for cardiovascular disease (CVD) and its risk factors and to identify predictors of CVD, blood pressure, and blood cholesterol screening.
Patients and methods: This cross-sectional study was conducted in 48 primary healthcare centers in Saudi Arabia and 14,239 participants were enrolled. The analysis was performed in SPSS version 26 and adjusted odds ratios (AOR) and 95% Cis were reported.
Results: Blood pressure screening was reported by 35.3%, cholesterol screening by 9.3%, and cardiovascular screening by 3.7%. Significant positive predictors for blood pressure screening included older age (50-75 years: AOR 1.34, 95% CI: 1.20-1.50; ≥75 years: AOR 2.12, 95% CI: 1.84-2.43), being married (AOR: 1.15; 95% CI: 1.04-1.27), non-smoking (AOR: 1.97; 95% CI: 1.79-2.17), physical activity (AOR: 1.16; 95% CI: 1.05-1.28), and diabetes (AOR: 2.14; 95% CI: 1.88-2.44). For cholesterol screening, significant positive predictors were older age (≥75 years: AOR 1.89, 95% CI: 1.56-2.29), unemployment (AOR: 1.26; 95% CI: 1.10-1.45), insurance coverage (AOR: 1.52; 95% CI: 1.33-1.74), smoking (AOR: 1.32; 95% CI: 1.14-1.53), diabetes history (AOR: 1.33; 95% CI: 1.09-1.61), and hypertension (AOR: 1.66; 95% CI: 1.36-2.02). For cardiovascular screening, significant positive predictors included older age (≥75 years: AOR 1.81, 95% CI: 1.35-2.43), unemployment (AOR: 1.53; 95% CI: 1.24-1.88), insurance coverage (AOR: 1.56; 95% CI: 1.27-1.92), smoking (AOR: 1.89; 95% CI: 1.52-2.34), diabetes (AOR: 1.85; 95% CI: 1.41-2.43), and high cholesterol (AOR: 1.76; 95% CI: 1.31-2.36).
Conclusion: A very low proportion of Saudi residents have undergone blood pressure, cholesterol, and CVD screening. Common predictors of screening included older age, insurance coverage, diabetes, hypertension, physical activity, and high cholesterol levels. Low prevalence of screening is alarming, and Saudi Government needs to implement strategies that can help increase proportion of Saudi residents who receive blood pressure, cholesterol, and CVD screening.
期刊介绍:
Patient Preference and Adherence is an international, peer reviewed, open access journal that focuses on the growing importance of patient preference and adherence throughout the therapeutic continuum. The journal is characterized by the rapid reporting of reviews, original research, modeling and clinical studies across all therapeutic areas. Patient satisfaction, acceptability, quality of life, compliance, persistence and their role in developing new therapeutic modalities and compounds to optimize clinical outcomes for existing disease states are major areas of interest for the journal.
As of 1st April 2019, Patient Preference and Adherence will no longer consider meta-analyses for publication.